openPR Logo
Press release

Hereditary Angioedema Therapeutics Market - Forecast to 2026

Hereditary Angioedema Therapeutics Market

Hereditary Angioedema Therapeutics Market

As per the research conducted by GME, the Global Hereditary Angioedema Therapeutics Market will grow with a CAGR value of 8.2%. Population growth, as well as lifestyle changes, improved insurance programs, and increased efforts by pharmaceutical and biotechnology companies to develop new products and solutions for the industry, are expected to fuel market revenue for Hereditary Angioedema in the years ahead.

Browse 153 Market Data Tables and 113 Figures spread through 183 Pages and in-depth TOC on “Global Hereditary Angioedema Therapeutics Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-hereditary-angioedema-therapeutics-market-3095

By Drug Class [C1-esterase Inhibitor, Bradykinin B2 Receptor Antagonist, Kallikrein Inhibitor, Others], By Treatment Type [Prophylaxis, On-demand], By Route of Administration [Intravenous, Subcutaneous, Oral], By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa); End-User, Landscape, Company Market Share Analysis, and Competitor Analysis
Key Market Insights
• Hereditary angioedema is a relatively uncommon genetic disorder. Rare diseases have become more common in recent years as global monitoring of their occurrence has increased over the last few decades.
• The Hereditary Angioedema Association is predicted to play an important role in spreading new therapies around the world.
• The swelling of tissues in the limbs, feet, digestive tract, face, or airway is caused by the flow of blood or lymphatic fluid, or the constant retention of fluids outside the blood vessels.
• According to the National Institutes of Health, hereditary angioedema affects about one in every 50,000 people.
• Subcutaneous injections as a mode of drug administration are expected to see a rise in demand due to an increase in demand for easy-to-use patients.
• BioCryst Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; Pharming Group N.V.; CSL Limited; Shire Plc; Attune Pharmaceuticals, Inc.; Adverum Biotechnologies, Inc.; and KalVista Pharmaceuticals, Inc. are the top players in the Hereditary Angioedema Therapeutics Market.
• In April 2021, BioCryst’s product ORLADEYOTM (berotralstat), the first oral, once-daily therapy to prevent attacks in patients with hereditary angioedema, has been approved by the European Commission.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-hereditary-angioedema-therapeutics-market-3095

Drug Class Outlook (Revenue, USD Billion, 2021-2026)
• C1-esterase inhibitor
• Bradykinin B2 receptor antagonist
• Kallikrein inhibitor
• Others

Treatment Type Outlook (Revenue, USD Billion, 2021-2026)
• Prophylaxis
• On-demand

Route of Administration Outlook (Revenue, USD Billion, 2021-2026)
• Intravenous
• Subcutaneous
• Oral

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hereditary Angioedema Therapeutics Market - Forecast to 2026 here

News-ID: 2282832 • Views: 327

More Releases from Global Market Estimates Research & Consultants

Global Bipolar Forceps Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Bipolar Forceps Market is projected to grow at a CAGR of 4.5% from 2022 to 2027. The rise in the prevalence of diseases that require microsurgery, as well as increased awareness of diseases and infections, will drive the bipolar forceps market forward. Furthermore, government measures aimed at improving healthcare infrastructure are anticipated to augment market growth during
Global Online Live Video Sports Streaming Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Online Live Video Sports Streaming Market is projected to grow at a CAGR of 21.5% from 2022 to 2027. The primary aspect driving the market is the increased interest among people in sports. Other factors driving the growth of the worldwide sports online live video streaming market include high-speed broadband and an upsurge in multi-platform and device-connected
Global Geotechnical Services Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Geotechnical Services Market is projected to grow at a CAGR of 6.5% from 2022 to 2027. Continuous growth in urbanization, a breakthrough in green building materials, rising investments in infrastructural developments, particularly in developing countries, and the relevance of geotechnical services in planning and lowering risk associated with project development and long-term investment is fueling market expansion. Browse
Global Ship Repair and Maintenance Services Market
According to a new market research report published by Global Market Estimates, the Global Ship Repair and Maintenance Services Market is projected to grow at a CAGR of 5.9% from 2022 to 2027. Major driving factors influencing the market growth during the forecast period are the increasing use of waterways for transportation, the growing popularity of cruise tourism, and the growing preference for ships such as container ships, bulk carriers, tanker

All 5 Releases


More Releases for Hereditary

Hereditary Testing Market Size – Forecasts to 2026
The results analyzed by GME showed that the Global Hereditary Testing Market will grow with a CAGR value of 7.1 percent, to hit xx billion USD by 2026. During the forecast timeframe, growth is expected to be driven by growing expenditure on R&D activities and the rising incidence of chronic diseases worldwide. The development may be attributed to the advancement of genetic testing services and the growing demand for personalized
Hereditary Angioedema Market Current Overview by 2025
flow of blood or lymphatic fluid, continuous accumulation of fluids outside of the blood vessels, results in swelling of tissues in the arms, feet, intestinal tract, face, or airway. Stress or Minor trauma may also trigger an attack, Swelling in the airway can limit breathing and prompt to life-debilitating obstruction of the airway. Around 33% of individuals with this condition faces non-itchy rash called erythema marginatum at the time of
Hereditary Angioedema Market is propelled by rise in hereditary angioedema (HAE) …
Some of the prominent names operating in the global hereditary angioedema market are Pharming Group NV, Shire plc, CSL Limited, Ionis Pharmaceuticals, Inc., iBio Inc., and BioCryst Pharmaceuticals, Inc. As per a report by Transparency Market Research, the global hereditary angioedema market will likely rise at a healthy 9.1% CAGR between 2017 and 2025 to become worth US$3.81 bn by 2025 from US$ 1.73 bn in 2016. Read Report Overview: https://www.transparencymarketresearch.com/hereditary-angioedema-market.html Superior Healthcare
Hereditary Angioedema Market Analysis & Key Trends 2025
As per a report by Transparency Market Research, the global hereditary angioedema market will likely rise at a healthy 9.1% CAGR between 2017 and 2025 to become worth US$3.81 bn by 2025 from US$ 1.73 bn in 2016. Progress in Diagnosis Catalyzing Growth in Market Hereditary angioedema is a rare disease that is estimated to affect 1 in 30,000 to 1 in 50,000 people worldwide. Hereditary angioedema is often mistaken for common
Hereditary Angioedema Market : Global Forecast over 2025
As per a report by Transparency Market Research, the global hereditary angioedema market will likely rise at a healthy 9.1% CAGR between 2017 and 2025 to become worth US$3.81 bn by 2025 from US$ 1.73 bn in 2016. Superior Healthcare Facilities Makes North America Market Leader Depending upon the class of drugs, the global hereditary angioedema market can be segmented into C1 Esterase Inhibitor, Selective Bradykinin B2 Receptor Antagonist, and Kallikrein Inhibitor,
Hereditary Angioedema Market Analysis & Key Trends 2025
As per a report by Transparency Market Research, the global hereditary angioedema market will likely rise at a healthy 9.1% CAGR between 2017 and 2025 to become worth US$3.81 bn by 2025 from US$ 1.73 bn in 2016. Progress in Diagnosis Catalyzing Growth in Market Hereditary angioedema is a rare disease that is estimated to affect 1 in 30,000 to 1 in 50,000 people worldwide. Hereditary angioedema is often mistaken for common